Page Not Found
Page not found. Your pixels are in another canvas.
A list of all the posts and pages found on the site. For you robots out there is an XML version available for digesting as well.
Page not found. Your pixels are in another canvas.
About me
This is a page not in th emain menu
Published:
This post will show up by default. To disable scheduling of future posts, edit config.yml and set future: false.
Published:
This is a sample blog post. Lorem ipsum I can’t remember the rest of lorem ipsum and don’t have an internet connection right now. Testing testing testing this blog post. Blog posts are cool.
Published:
This is a sample blog post. Lorem ipsum I can’t remember the rest of lorem ipsum and don’t have an internet connection right now. Testing testing testing this blog post. Blog posts are cool.
Published:
This is a sample blog post. Lorem ipsum I can’t remember the rest of lorem ipsum and don’t have an internet connection right now. Testing testing testing this blog post. Blog posts are cool.
Short description of portfolio item number 1
Short description of portfolio item number 2 
Published in Trials, 2022
While inhaled corticosteroids (ICS) are considered the essential foundation of most asthma therapy, ICS inhaler nonadherence is a notoriously common problem and a significant cause of asthma-related morbidity. Partially acknowledging the problem of nonadherence, international organizations recently made paradigm-shifting recommendations that all patients with mild-to-moderate persistent asthma be considered for symptom-driven ICS-containing inhalers rather than relying on adherence to traditional maintenance ICS inhalers and symptom-driven short-acting beta-agonists (SABA). With this new approach, asthma patients are at least exposed to the important anti-inflammatory effects of ICS-containing inhalers when their symptom reliever inhaler is deployed due to acute symptoms.
Recommended citation: Krings, J.G., Wojcik, K.M., Chen, V. et al. Symptom-driven inhaled corticosteroid/long-acting beta-agonist therapy for adult patients with asthma who are non-adherent to daily maintenance inhalers: a study protocol for a pragmatic randomized controlled trial. Trials 23, 975 (2022). https://doi.org/10.1186/s13063-022-06916-3 (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9720948/)
Published:
Podium talk during the “Advances in Cancer Modeling” session
Published:
Poster presentation, part of the Lee Lusted Student Prize competition
Published:
Poster presentation, part of the Lee Lusted Student Prize competition
Undergraduate course, University 1, Department, 2014
This is a description of a teaching experience. You can use markdown like any other post.
Workshop, University 1, Department, 2015
This is a description of a teaching experience. You can use markdown like any other post.